Cutia Therapeutics (2487.HK)

HKD 6.95

(0.14%)

Revenue Summary of Cutia Therapeutics

  • Cutia Therapeutics's latest annual revenue in 2023 was 137.62 Million CNY , up 1110.83% from previous year.
  • Cutia Therapeutics's latest quarterly revenue in 2024 Q2 was 47.78 Million CNY , down 0.0% from previous quarter.
  • Cutia Therapeutics reported a annual revenue of 11.36 Million CNY in annual revenue 2022, up 457.7% from previous year.
  • Cutia Therapeutics reported a annual revenue of 2.03 Million CNY in annual revenue 2021, down 0.0% from previous year.
  • Cutia Therapeutics reported a quarterly revenue of 47.78 Million CNY for 2024 Q1, down -7.46% from previous quarter.
  • Cutia Therapeutics reported a quarterly revenue of 51.64 Million CNY for 2023 Q4, down 0.0% from previous quarter.

Annual Revenue Chart of Cutia Therapeutics (2023 - 2021)

Historical Annual Revenue of Cutia Therapeutics (2023 - 2021)

Year Revenue Revenue Growth
2023 137.62 Million CNY 1110.83%
2022 11.36 Million CNY 457.7%
2021 2.03 Million CNY 0.0%

Peer Revenue Comparison of Cutia Therapeutics

Name Revenue Revenue Difference
Uni-Bio Science Group Limited 484.71 Million HKD 71.608%
CK Life Sciences Int'l., (Holdings) Inc. 5.32 Billion HKD 97.414%